CSPC Pharms Grp (CSPCY) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 32 217 sessions, November 6, 2025 to November 6, 2026
- Largest daily move
- +13.3% close of March 27, 2026
- 1-year change
- +10.8% closing prices, November 6, 2025 to November 6, 2026
- 1-month change
- -15.1% closing prices, October 6, 2026 to November 6, 2026
Company Description
CSPC Pharms Grp (OTC: CSPCY) is classified in the drug manufacturers - general industry within the Healthcare sector and carries a market capitalization of $12.2B.
CSPCY has gained 10.8% over the past year. The last closing price was $4.27.
This page collects what Stock Titan holds for CSPCY, including price data, latest news, and short interest trends.
Stock Performance
CSPC Pharms Grp (CSPCY) closed at $4.27 on November 6, 2026. Over the past 12 months, the price has gained 10.8%.
CSPCY Metrics & Rankings
Price returns through November 6, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
CSPC Pharms Grp has 4 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial. View all CSPCY news →
SEC Filings
Short Interest History
Short interest in CSPC Pharms Grp (CSPCY) currently stands at 1.3 thousand shares, down 54.3% from the previous reporting period. Since November 2025, short interest has decreased by 64.9%.
Days to Cover History
Days to cover for CSPC Pharms Grp (CSPCY) currently stands at 1.0 days, down 61.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 3.9 days.
CSPCY Company Profile & Sector Positioning
CSPC Pharms Grp (CSPCY) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CSPCY often look at related companies in the same sector, including Astellas Pharma (ALPMY), Daiichi Sankyo (DSNKY), Otsuka Holdings Co (OTSKY), Grifols SA Barc (GIFLF), and Chugai Pharm (CHGCY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CSPCY's relative position within its industry.